NCT01691664

Adoptive Cellular Therapy and Radiation Therapy After Surgery in Treating Patients With Esophageal Cancer

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Capital Medical University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Cytokine-induced killer (CIK) cells show cytolytic activity against tumor. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining Radiation therapy with adoptive cellular therapy after surgery may be more effective than uses radiation therapy alone in treating esophageal cancer.

Conditions

• Esophageal Cancer

Interventions

Type	Name	Description
RADIATION	Only radiation therapy	Patients only radiation therapy after surgery
OTHER	Radiation therapy plus DC-CIK cellular therapy	Patients receive radiation therapy plus DC-CIK cellular therapy after surgery

Timeline

• Start date: 2012-09-01
• Primary completion: 2021-12-01
• Completion: 2022-06-01
• First posted: 2012-09-25
• Last updated: 2019-11-04

Locations

1 site across 1 country: China